ASAnne-Pascale Satie

Anne-Pascale Satie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anne-Pascale Satie has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Nathalie Dejucq-Rainsford

    Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085 , Rennes

    3 shared publications
  • André Cabié

    University Hospital of Martinique, Infectious Diseases and Tropical Medicine Unit, F-97200, Martinique; Caribbean Clinical Investigation Center, Inserm CIC 2504, University Hospital of Martinique, Fort-de-France, France; PCCEI, Univ Montpellier, INSER

    1 shared publication
  • Anissa Moktefi

    Univ Paris Est Creteil, Creteil, France

    1 shared publication
  • Anna Le Tortorec

    Department of Infectious Disease, King’s College London School of Medicine, Guy’s Hospital, London SE1 9RT, UK

    1 shared publication
  • Anna Le Tortorec

    Université de Rennes, Inserm, École des hautes études en santé publique (EHESP), Institut de recherche en santé, environnement et travail (Irset) - UMR_S1085, Rennes, France

    1 shared publication
  • Anne-Elisabeth Heng

    Service de Néphrologie, Dialyse, Transplantation, CHU (Centre Hospitalier Universitaire) Clermont-Ferrand, UMR 1019, INRA (Institut National de la Recherche Agronomique), Université Clermont Auvergne, Clermont-Ferrand, France

    1 shared publication

Latest Publications

  • Open Access

    Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases

    by Romain Arrestier, Anne-Pascale Satie, Shao-Yu Zhang, Emmanuelle Plaisier, Corinne Isnard-Bagnis, Philippe Gatault, Quentin Raimbourg, David Buob, Flavia Vocila, Anne-Elisabeth Heng, et al.

    Human immunodeficiency virus (HIV) is associated with diverse glomerular diseases. Characteristics of minimal change nephrotic syndrome (MCNS) in this setting have been little studied, and the specific features of this uncommon association remain to be determined. We conduct a retrospective study. Clinical, biological and pathological characteristics of patients with MCNS and HIV infection were assessed. We evaluated HIV infection by in situ hybridization and CMIP expression by immunochemistry on kidney biopsies and compared it to HIV-associated nephropathy (HIVAN) and idiopathic MCNS. Eight patients were identifies. In all but one of these cases, MCNS occurred after HIV diagnosis (mean of 9.5 years). Acute kidney injury was detected in three cases. Mean CD4+ lymphocyte count was 733/mm3 and three patients had a detectable HIV viral load. In situ hybridization for HIV-1 RNA detection yielded a positive signal in a few tubular cells in the renal parenchyma in two of four patients with HIV infection associated with MCNS. Podocytes of these patients presented strong positive immunostaining for CMIP (4/4). Three patients suffered steroid-dependent nephrotic syndrome, and another two patients had at least one relapse. Rituximab treatment was initiated in four cases. After a median follow-up of 20 months, all patients were in remission (complete in 5 cases). In patients with MCNS occurring in a context of HIV infection, podocyte injury seems to be associated with CMIP induction rather than renal HIV infection but further studies are needed to determine the molecular link between these two conditions.


  • Open Access

    Zika virus infects human testicular tissue and germ cells

    by Giulia Matusali, Laurent Houzet, Anne-Pascale Satie, Dominique Mahé, Florence Aubry, Thérèse Couderc, Julie Frouard, Salomé Bourgeau, Karim Bensalah, Sylvain Lavoué, et al.

    Zika virus (ZIKV) is a teratogenic mosquito-borne flavivirus that can be sexually transmitted from man to woman. The finding of high viral loads and prolonged viral shedding in semen suggests that ZIKV replicates within the human male genital tract, but its target organs are unknown. Using ex vivo infection of organotypic cultures, we demonstrated here that ZIKV replicates in human testicular tissue and infects a broad range of cell types, including germ cells, which we also identified as infected in semen from ZIKV-infected donors. ZIKV had no major deleterious effect on the morphology and hormonal production of the human testis explants. Infection induced a broad antiviral response but no IFN upregulation and minimal proinflammatory response in testis explants, with no cytopathic effect. Finally, we studied ZIKV infection in mouse testis and compared it to human infection. This study provides key insights into how ZIKV may persist in semen and alter semen parameters, as well as a valuable tool for testing antiviral agents.


  • Open Access

    Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo

    by Anna Le Tortorec, Anne-Pascale Satie, Hélène Denis, Nathalie Rioux-Leclercq, Laurence Havard, Annick Ruffault, Bernard Jégou, Nathalie Dejucq-Rainsford

    Background: In order to determine whether human prostate can be productively infected by HIV-1 strains with different tropism, and thus represent a potential source of HIV in semen, an organotypic culture of prostate from men undergoing prostatic adenomectomy for benign prostate hypertrophy (BPH) was developed. The presence of potential HIV target cells in prostate tissues was investigated using immunohistochemistry. The infection of prostate explants following exposures with HIV-1 R5, R5X4 and X4 strains was analyzed through the measure of RT activity in culture supernatants, the quantification of HIV DNA in the explants and the detection of HIV RNA+ cells in situ. Results: The overall prostate characteristics were retained for 21/2 weeks in culture. Numerous potential HIV-1 target cells were detected in the prostate stroma. Whilst HIV-1 R5SF162 strain consistently productively infected prostatic T lymphocytes and macrophages, the prototypic X4IIIB strain and a primary R5X4 strain showed less efficient replication in this organ. Conclusion: The BPH prostate is a site of HIV-1 R5 replication that could contribute virus to semen. A limited spreading of HIV-1 X4 and R5X4 in this organ could participate to the preferential sexual transmission of HIV-1 R5 strains.